Blood transfusion

United States Infusion Therapy Market Analysis & Forecasts, 2019-2022 & 2023-2029: Infusion Pumps, Intravenous Sets, Needless Connectors, Stopcocks, Intravenous Filters & Blood Transfusion Devices - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 8, 2023
Pharmaceutical, Health, Medical Devices, Infusion, IV, FDA recall policies, Pump, Baxter, COVID-19, Texas Homecare, BD (company), Russian Industrial Leaders Index, CareFusion, Blood transfusion, Flow control, Intravenous therapy, Market, SWOT, Acquisition, SCSI Peripheral Device Type, ICU Medical, Mergers and acquisitions, Infusion pump, Growth, Patient, Stopcock, FDA, Disruptive innovation, Needleless connector, Medical device, Pharmaceutical industry, Medical imaging, Modularity

The "United States Infusion Therapy Market Size, Share & COVID-19 Impact Analysis 2023-2029 | MedSuite | Includes: Infusion Pumps, Intravenous Sets, Needless Connectors, Stopcocks, Intravenous Filters & Blood Transfusion Devices" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Infusion Therapy Market Size, Share & COVID-19 Impact Analysis 2023-2029 | MedSuite | Includes: Infusion Pumps, Intravenous Sets, Needless Connectors, Stopcocks, Intravenous Filters & Blood Transfusion Devices" report has been added to ResearchAndMarkets.com's offering.
  • The Infusion Therapy Device Market in the United States had a valuation of $3 billion in 2022.
  • The full report suite on the U.S. Market for Infusion Therapy Devices includes extensive analysis on the following segments: Infusion Pump Market, Intravenous Set Market, Needleless Connector Market, Stopcock Market, Intravenous Filter Market, and the Blood Transfusion Market.
  • The infusion therapy device market, being mature and stable, is expected to witness limited growth in unit sales.

The Blood Connection Opens New Donation Center in Anderson, SC on World Blood Donor Day

Retrieved on: 
Friday, June 9, 2023
Tim Scott, State, Municipal council, Partnership, World Blood Donor Day, Friends, AnMed Health Medical Center, SC, T. L. Hanna High School, Blood transfusion, Patient, Blood, TBC, Family, Commerce, Medical device, Upstate

ANDERSON, S.C., June 9, 2023 /PRNewswire/ -- The Blood Connection is celebrating World Blood Donor Day with the grand opening of its newest donation center in Anderson, SC. The center is now open at 101 Hanna Crossing in Anderson, SC – across from T.L. Hanna High School. A ribbon cutting ceremony will be held at 10:30 am on Wednesday, June 14th in partnership with the Anderson Chamber of Commerce. The ceremony will consist of local leaders, AnMed representatives, TBC blood donors, board members, and other special guests – including Anderson Mayor Terence Roberts, State Representative Thomas Beach, Danielle Gibbs from Senator Tim Scott's Office, and City Councilman Glenn Davis.

Key Points: 
  • Ribbon Cutting Ceremony on Wednesday, June 14
    ANDERSON, S.C., June 9, 2023 /PRNewswire/ -- The Blood Connection is celebrating World Blood Donor Day with the grand opening of its newest donation center in Anderson, SC.
  • We encourage everyone who can to donate blood at the new Anderson donation center and help us ensure those life-saving blood products remain continuously available for those who need them."
  • "This has been a long time coming for TBC and we are so thrilled to finally opening a donation center in Anderson.
  • "When an AnMed patient receives a blood transfusion, that blood is available only through The Blood Connection.

India Surgical Suture Market Report 2023-2027: Market Influences, Trends, Opportunities, & Restraints - ResearchAndMarkets.com

Retrieved on: 
Monday, June 5, 2023
Surgery, Health, Medical Supplies, CVD, Surgeon, Prevalence, Education, COVID-19, Consumer, Dialysis, Incidence, Blood transfusion, Patient, General surgery, Growth, GI, Urology, Silk, Medical device

The "Surgical Suture Market in India 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Surgical Suture Market in India 2023" report has been added to ResearchAndMarkets.com's offering.
  • In the healthcare sector, the use of surgical sutures is a necessary since they are required for the closure of the wound or incision.
  • Surgical sutures are used in a broad range of surgeries such as orthopaedic, urology, GI, CVD, and many other wound closure procedures.
  • The rising incidence and prevalence of cardiovascular diseases is expected to aid the growth of suture market in India.

Cerus Corporation Announces Follow-on Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate

Retrieved on: 
Monday, June 5, 2023
Other Defense, FDA, Health Technology, Contracts, White House, Federal Government, Other Health, General Health, Medical Devices, Defense, Hospitals, Public Policy, Government, Military, Biotechnology, Health, Medical Supplies, Bleeding, U.S. Department of Defense Strategy for Operating in Cyberspace, United States Department of Defense, Survival, Temperature, Military personnel, IBAS, Corporation, Blood transfusion, Patient, CERS, Trauma, Death, Cryoprecipitate, Pharmaceutical industry, Cerus Corporation

Cerus’ LyoCryo product is being designed for shelf stability, rapid availability, and portability, enabling administration to patients in remote environments with the aim of increasing survival from traumatic injury bleeding.

Key Points: 
  • Cerus’ LyoCryo product is being designed for shelf stability, rapid availability, and portability, enabling administration to patients in remote environments with the aim of increasing survival from traumatic injury bleeding.
  • Optimizing survival and recovery of military personnel with combat-related injury is a priority for the Army’s Combat Casualty Care Research Program.
  • For civilians, trauma with massive bleeding is the leading cause of death for people under the age of 45 years in the U.S.
  • We are gratified by the DoD’s decision to provide additional funding for this important project,” stated Dr. Laurence Corash, Cerus’ chief scientific officer and co-founder.

Gay men can now donate blood after FDA changes decades-old rule – a health policy researcher explains the benefits

Retrieved on: 
Tuesday, May 16, 2023
University, HIV, COVID-19, Risk assessment, Research, History, Health policy, Science, Man, AIDS, Blood transfusion, Time, Risk, Blood, Lifting, Knowledge, Human, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Safety, Pharmaceutical industry, Vaccine, Medical device, Birth control

Ayako Miyashita is a health policy researcher at the University of California, Los Angeles, who studies HIV treatment and prevention.

Key Points: 
  • Ayako Miyashita is a health policy researcher at the University of California, Los Angeles, who studies HIV treatment and prevention.
  • She explains the history of the ban and the reasoning behind its long-awaited reversal.

1. When and why did the ban begin?

    • When the FDA first implemented the blood donation ban in 1983 for men who have sex with men, there were good reasons for broad regulations to ensure the safety of the blood supply.
    • At the start of the AIDS epidemic, public health officials were dealing with an unknown virus that was spread through unknown means.
    • But over the years, scientific advancements and strict protocols have helped to nearly eliminate HIV transmission through blood.
    • In fact, the last documented transmission of HIV through the a U.S. donor’s blood product occurred nearly 15 years ago.

2. Why lift the ban now?

    • Researchers and public health officials have gained a better understanding of how HIV is transmitted and the risks associated with different activities.
    • Given today’s knowledge, many medical experts believe that the benefits of the ban no longer outweigh the hit to the blood supply or the harm caused by what is a discriminatory rule.
    • If the assessment finds an individual to be high-risk, then the guidelines recommend that person be prevented from donating blood for three months.

3. What effect could this have on the blood supply?

    • The FDA’s latest move represents a seismic shift for men who have sex with men as well as for the critically low U.S. blood supply.
    • According to recent research, a conservative estimate suggests that the lifting of the ban will lead to a 2% to 4% increase in the blood supply.
    • With the ongoing blood shortage, that increase could help save more than a million lives.

FDA Conditionally Approves First Drug for Anemia in Cats with Chronic Kidney Disease

Retrieved on: 
Monday, May 1, 2023
Thrombosis, Mouth, Chronic kidney disease, Center for Veterinary Medicine, Veterinarian, Oxygen, Food, Bone marrow, Quality of life, Medicine, Cat, Vomiting, Nephritis, Blood transfusion, Euthanasia, Animal, Blood, Erythropoietin, Cancer, Amyloidosis, Viral, Kidney, Thrombus, FDA, Veterinary medicine, Death, CKD, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Disease, Glomerulonephritis, Dietary supplement, Pharmaceutical industry

SILVER SPRING, Md. , May 1, 2023 /PRNewswire/ --Today, the U.S. Food and Drug Administration conditionally approved Varenzin-CA1 (molidustat oral suspension), the first drug for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats. Nonregenerative anemia can be a fatal condition because the cat's bone marrow is not able to produce enough red blood cells to replace the older or damaged red blood cells that are naturally removed from the blood, resulting in the inability for oxygen to be carried from the lungs throughout the body.

Key Points: 
  • , May 1, 2023 /PRNewswire/ --Today, the U.S. Food and Drug Administration conditionally approved Varenzin-CA1 (molidustat oral suspension), the first drug for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats.
  • CKD is a disease that requires day-to-day management in cats, and nonregenerative anemia is a complication that often contributes to death or euthanasia of affected cats due to poor quality of life.
  • Cats can develop CKD at any age, but it is frequently diagnosed in older cats.
  • The current treatments available for nonregenerative anemia in cats with CKD include blood transfusion, supplemental iron therapy and erythropoietin replacement.

LANDMARK BOOK "BLOOD WORKS: AN OWNER'S GUIDE" RELEASED GLOBALLY

Retrieved on: 
Tuesday, April 25, 2023
Blood Work, Vein, Blood, Johns Hopkins Hospital, City Point, Harvard Medical School, King's College London, Favourite, Simon & Schuster, Blood transfusion, Patient, Physician, Anemia, Health, TIME, Medicine, Ebook, Medical device, Book, Surgeon

The 456-page book is produced by a collective of 48 leading international medical experts.

Key Points: 
  • The 456-page book is produced by a collective of 48 leading international medical experts.
  • The book is jointly published by City Point Press and Human Touch Media Foundation and distributed by Simon & Schuster.
  • Readers' Favorite, the international book review and award group, commented: "This book is a benchmark for managing our health and options", and "has enormous lifesaving potential."
  • Paperbacks and eBooks are available from the official Blood Works: An Owner's Guide website and all major platforms.

San Diego Blood Bank Launches Innovative Precision Blood™ Expansion

Retrieved on: 
Monday, April 24, 2023
Research, Surgery, Hospitals, Genetics, Health Technology, Philanthropy, Biotechnology, Health, Foundation, Science, Learning, Antigen, Probability, Thalassemia, Life, Blood, Tree, Childbirth, Epistasis, Conrad, Antibody, Life expectancy, Precision, Interest, Hospital, Blood transfusion, Patient, Collection, Risk, Cancer, Medicine, Sickle cell disease, Knowledge, World Blood Donor Day, Leukemia, Harbor–UCLA Medical Center, Rest, Kidney disease, Medical device, Kamilla

San Diego Blood Bank (SDBB) today launched its groundbreaking Precision Blood™ initiative expansion, which the nonprofit healthcare organization believes can greatly improve the standard of care as we know it today for blood transfusion patients.

Key Points: 
  • San Diego Blood Bank (SDBB) today launched its groundbreaking Precision Blood™ initiative expansion, which the nonprofit healthcare organization believes can greatly improve the standard of care as we know it today for blood transfusion patients.
  • “We want people to know the thought of advanced medical research happening in the future is actually happening now with Precision Blood™,” says Nikhil Nayak, chief business officer, San Diego Blood Bank.
  • Thanks to generous blood donors and San Diego Blood Bank’s Precision Blood™ research, Kamila is now receiving blood that is more precisely matched.
  • “Precision Blood™ is the next logical step in our progression toward these goals and helping patients increase the probability of improved medical outcomes.”
    To learn more about San Diego Blood Bank and the Precision Blood™ initiative, please visit sandiegobloodbank.org/precision-blood .

Columbia Healthcare Analytics: Recent Study Indicates Hospitals Excessively Transfuse Blood

Retrieved on: 
Tuesday, March 28, 2023
Learning, Hepatitis, Bleeding, IV, Education, HIV, Infection, Quality, Blood transfusion, Patient, Collection, Physician, Blood, Erythropoietin, Disease, Hematinic, Patient safety, Death, Medical device, Pharmaceutical industry

SEATTLE, March 28, 2023 /PRNewswire-PRWeb/ -- Columbia Healthcare Analytics, Inc. released their recently published study results that indicate the need for additional education in blood transfusions.

Key Points: 
  • Columbia Healthcare Analytics, Inc. released their recently published study results that indicate the need for additional education in blood transfusions.
  • SEATTLE, March 28, 2023 /PRNewswire-PRWeb/ -- Columbia Healthcare Analytics, Inc. released their recently published study results that indicate the need for additional education in blood transfusions.
  • Additionally, blood can be "salvaged" by collection and washing, after which doctors can return the patient's blood rather than transfusing blood collected by local donor centers."
  • To read the complete study, go to the following: https://www.jointcommissionjournal.com/article/S1553-7250(22)00246-X/fulltext
    Columbia Healthcare Analytics, Inc. conducted this study.

Bay Area Lyme Foundation Celebrates Department of Defense CDMRP Tick-borne Disease Awardees

Retrieved on: 
Thursday, March 23, 2023
Columbia University, Tufts University, Duke University, Biobank, Notifiable disease, Doctor of Pharmacy, Virginia Tech, Therapy, Lyme disease, Babesiosis, Frontiers, Gastrointestinal tract, Infection, COVID-19, DNA sequencing, AGS, Immunoglobulin M, PCR, MBA, Research, Immunoglobulin A, Tick, Antibody, Peptidoglycan, Veteran, Tick-Borne Disease Alliance, Johns Hopkins University, Blood transfusion, Patient, Risk, Blood, Immunoglobulin G, DVM, NIH, MBI, Skin, Vaccine, Microbiology, Doctor of Philosophy, MD

PORTOLA VALLEY, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation , a leading sponsor of Lyme disease research in the US, announces that two projects it has previously funded have now received Department of Defense Congressionally Directed Medical Research Programs (CDMRP) Tick-Borne Disease awards.

Key Points: 
  • PORTOLA VALLEY, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation , a leading sponsor of Lyme disease research in the US, announces that two projects it has previously funded have now received Department of Defense Congressionally Directed Medical Research Programs (CDMRP) Tick-Borne Disease awards.
  • Three of the six recently announced CDMRP awardees will be using biological samples from Bay Area Lyme Foundation’s Lyme Disease Biobank to enable their research into diagnostics and therapeutics for tick-borne diseases, including Lyme disease—which infects half a million people each year.
  • Peter Gwynne, research assistant professor in Hu's lab, was a Bay Area Lyme Foundation ELA winner in 2022 and has used samples from the Lyme Disease Biobank.
  • Jutras was a Bay Area Lyme Foundation ELA winner in 2021 and his lab will be using samples from the Lyme Biobank to validate their novel diagnostics.